CVS Caremark Co. (CVS) Updates FY14 Earnings Guidance
CVS Caremark Co. (NYSE:CVS) updated its FY14 earnings guidance on Tuesday. The company provided earnings per share guidance of $4.43-4.51 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.46, American Banking and Market News reports. CVS Caremark also updated its Q3 guidance to $1.11-1.14 EPS.
A number of research firms have recently commented on CVS. Analysts at Susquehanna raised their price target on shares of CVS Caremark from $85.00 to $90.00 in a research note on Friday, June 6th. They now have a positive rating on the stock. On a related note, analysts at Zacks reiterated a neutral rating on shares of CVS Caremark in a research note on Thursday, May 29th. They now have a $81.00 price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of CVS Caremark from $80.00 to $83.00 in a research note on Wednesday, May 28th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company’s stock. CVS Caremark has a consensus rating of Buy and a consensus price target of $77.63.
Shares of CVS Caremark Co. (NYSE:CVS) opened at 78.36 on Tuesday. CVS Caremark Co. has a 1-year low of $56.32 and a 1-year high of $79.43. The stock has a 50-day moving average of $76.8 and a 200-day moving average of $74.16. The company has a market cap of $91.916 billion and a price-to-earnings ratio of 19.70. CVS Caremark also saw unusually large options trading activity on Monday. Stock investors purchased 7,359 put options on the company. This represents an increase of 776% compared to the typical daily volume of 840 put options.
CVS Caremark (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter in the previous year, the company posted $0.97 earnings per share. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. Analysts expect that CVS Caremark Co. will post $4.46 EPS for the current fiscal year.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.